Pharmacokinetics of iodine-125 CC49 monoclonal antibody in patients with colon cancer

Cancer Biotherapy and Radiopharmaceuticals

Volumn 11, Issue 6, 1996, Pages 415-422

  Cook, Charles H ^a   Hinkle, George H ^a   Thurston, Marlin O ^a   Martin Jr , Edward W ^a  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

Author keywords

125I CC49 MAb; pharmacokinetics

Indexed keywords

IODINE 125; MONOCLONAL ANTIBODY CC49;

ADULT; AGED; ANTIGEN ANTIBODY COMPLEX; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COLON CANCER; DEIODINATION; DRUG BLOOD LEVEL; DRUG HALF LIFE; DRUG METABOLISM; DRUG URINE LEVEL; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; INTRAVENOUS DRUG ADMINISTRATION; MALE; PHARMACOKINETICS; PRIORITY JOURNAL; RADIOIODINATION;

EID: 0030459163     PISSN: 10849785     EISSN: None     Source Type: Journal    
DOI: 10.1089/cbr.1996.11.415     Document Type: Article

References (26)

1. Cancer Facts & Figures - 1995 Atlanta, GA: American Cancer Society, 1995:9-10.
2. DeVita, Jr VT, Hellman S, Rosenberg SA. Cancer:Principle and Practice of Oncology Fourth Edition, Philadelphia: J.B. Lippincott, 1993;930.
3. Hinkle GH, Mojzisit CM, Loesch JA, et al. The evolution of the Radioimmunoguided Surgery™ system: An innovative technique for the intraoperative detection of tumor. Antibody Immunoconj Radiophar 1991;4:339-358.
4. LaValle GJ, Chevinsky A, Martin, Jr EW. Impact of Radioimmunoguided Surgery®. Sem Surg Oncol 1991;7:167-170.
5. Thor A, Ohuchi N, Szpak CA, et al. The distribution of oncofetal antigen TAG-72 defined by monoclonal antibody B72.3. Cancer Res 1986;46:3118-3124.
6. Schneebaum S, Ritter DC, Burak,Jr WE Radioimmunoguided Surgery™ primary clinical trials and applications. Sem Col Rec Surg 1995;6:217-225
7. Carrasquillo JA, Sugarbaker P, Colcher D, et al. Radioimmunoscintigraphy of colon cancer with iodine-131-labeled B72.3 monoclonal antibody. J Nucl Med 1988,29:1022-1030.
8. 111In-labeled B72 3 monoclonal antibody Cancer Res (SUPPL) 1990;50.932s-936s.
9. Schlabach TD, Abbott SR. Serum protein profiles by "high performance" liquid chromatography with detection at multiple wavelengths. Clin Chem 1980;26 1504-1508
10. Andersson T, Hagel L. Some properties and applications of Superose 6B. Analytical Biochem 1984;141:461-465
11. Hnatowich DJ, Griffin TW, Kosciuszyk C, et al. Pharmacokinetics of an indium-111-labeled monoclonal antibody in cancer patients. J Nucl Med 1985;26:849-858
12. Colcher D, Mlenic DE, Ferroni P, et al In vivo fate of monoclonal antibody B72.3 in patients with colorectal cancer. J Nucl Med 1990,31:1133-1142.
13. Cooper EH, Turner R, Johns EA, et al. Applications of fast protein liquid chromatography in the separation of plasma proteins in urine and cerebrospinal fluid. Clin Chem 1983;29:1635-1640.
14. Ratge D, Wisser H. Urinary protein profiling by high performance gel permeation chromatography. J Chromat 1982;230:42-56.
15. Harrison JF, Northam BE. Low molecular weight urine protein investigated by gel filtration. Clinica Chemica Acta 1966;14:679-688.
16. Davis JS, Flynn FV, Platt HS. The characterization of urine protein by gel filtration. Clinica Chemica Acta 1968;21:357-376.
17. Muraro R, Kuroki M, Wunderlich D, et al. Generation and characterization of B72.3 second generation monoclonal antibodies reactive with tumor associated glycoprotein 72 antigen. Cancer Res 1988;48:4588-4596.
18. Colcher D, Minelli MF, Roselli M, et al Radioimmunolocalization of human carcinoma xenografts with B72.3 second generation (CC) monoclonal antibodies. Cancer Res 1988;48:4597-4603.
19. Fraker PJ, Speck JC. Protein and cell membrane iodinations with a sparingly soluble chloramide 1,3,4,6-tetrachloro-3α,6α-diphenylglycouril. Biochem Biophys Res Commun 1978; 80:849-857.
20. Hinkle GH, Laven DL. Radionuclides. In Martin,Jr. EW, ed. Radioimmunoguided Surgery (RIGS) in the Detection and Treatment of Colorectal Cancer. Austin, TX: Landes; 1994:29-39
21. Hinkle GH, Beightol RW, Gregorio N, Lefevre SR. Pharmacy considerations related to radiolabeled monoclonal antibodies. Pharm Pract 1989;2:177-184.
22. Ganong WF. Review of Medical Physiology, 14th edition Norwalk, CT Appleton & Lange: 1989:196-203.
23. Sullivan DC, Silva JS, Cox CE, et al. Localization of 1-131 labeled goat and primate anti-carcinoembryonic antigen (CEA) Invest Radiol 1982;7:350-355.
24. Waldmann TA, Strober W Metabolism of immunoglobulins. Progr Allergy 1969;13:1-110.
25. Khaw BA, Cooney J, Edgington T, Strauss HW. Differences in experimental tumor localization of dual labeled monoclonal antibody. J Nucl Med 1986;27 1293-1299.
26. Hagan PL, Halpern SE, Chen A, et al. In vivo kinetics of radiolabeled monoclonal anti-CEA antibodies in animal models J Nucl Med 1985;26:1418-1423